Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shen Lu

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Academic Radiology|December 4, 2010
The association of infrared imaging findings of the breast with hormone receptor and human epidermal growth factor receptor 2 status of breast cancerJane Wang, Tiffany Ting-Fang Shih, Ruoh-Fang Yen, et al.
Acta Pharmacologica Sinica|May 7, 2026
CYFIP2 deficiency ameliorates renal interstitial fibrosis through attenuating tubular senescence in hypertensive nephropathyMing-Chen Sun, Fu-Wen Zuo, You-Zhao Wang, et al.
Breast Cancer Research and Treatment|August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trialsManuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
Biochemistry|June 15, 2005
Accessibility of the distal heme face, rather than Fe-His bond strength, determines the heme-nitrosyl coordination number of cytochromes c': evidence from spectroscopic studiesColin R Andrew, Lenord J Kemper, Tammy L Busche, et al.
Japanese Journal of Clinical Oncology|January 21, 2010
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatinYu-Yun Shao, Kuan-Ting Kuo, Fu-Chang Hu, et al.
Environment International|June 25, 2020
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese womenMeng-Shan Tsai, Shu-Han Chang, Wen-Hung Kuo, et al.
Japanese Journal of Clinical Oncology|January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerTom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
Scientific Reports|May 11, 2017
Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelinesXiao Mao, Kai Li, Beisha Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR<sup>+</sup> Advanced Breast CancerSara M Tolaney, Young-Hyuck Im, Emiliano Calvo, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Academic Radiology|December 4, 2010
The association of infrared imaging findings of the breast with hormone receptor and human epidermal growth factor receptor 2 status of breast cancerJane Wang, Tiffany Ting-Fang Shih, Ruoh-Fang Yen, et al.
Acta Pharmacologica Sinica|May 7, 2026
CYFIP2 deficiency ameliorates renal interstitial fibrosis through attenuating tubular senescence in hypertensive nephropathyMing-Chen Sun, Fu-Wen Zuo, You-Zhao Wang, et al.
Breast Cancer Research and Treatment|August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trialsManuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
Biochemistry|June 15, 2005
Accessibility of the distal heme face, rather than Fe-His bond strength, determines the heme-nitrosyl coordination number of cytochromes c': evidence from spectroscopic studiesColin R Andrew, Lenord J Kemper, Tammy L Busche, et al.
Japanese Journal of Clinical Oncology|January 21, 2010
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatinYu-Yun Shao, Kuan-Ting Kuo, Fu-Chang Hu, et al.
Environment International|June 25, 2020
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese womenMeng-Shan Tsai, Shu-Han Chang, Wen-Hung Kuo, et al.
Japanese Journal of Clinical Oncology|January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerTom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
Scientific Reports|May 11, 2017
Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelinesXiao Mao, Kai Li, Beisha Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR<sup>+</sup> Advanced Breast CancerSara M Tolaney, Young-Hyuck Im, Emiliano Calvo, et al.
NPJ Breast Cancer|July 6, 2021
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaChing-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, et al.
Pageof 24